On June 30, 2017, the Centers for Medicare & Medicaid Services (CMS) released its 2016 Open Payments financial data (https://openpaymentsdata.cms.gov/). As a reminder, under Section 6002 of the Affordable Care Act (also known as the Physician Payments Sunshine Act) manufacturers of “covered drugs, devices, biologicals, and medical supplies” are required to report payments or other transfers of value to physicians to CMS. It further requires that drug and device manufacturers and group purchasing organizations (GPOs) report physicians’ (or their family members’) ownership and investment interests in these companies.
As part of a broader effort to increase transparency in financial ties between industry and physicians, the 2016 data release complements reporting from previous years but organizes the information slightly differently. In this article, I will review, as I did last year (see “Open Payments: How urology measures up"), some summary information and analysis about the specialty as it pertains to Open Payments data.